VANDA PHARMACEUTICALS (VNDA) Covered Calls

VANDA PHARMACEUTICALS covered calls Vanda Pharmaceuticals Inc. is a biopharmaceutical Company focusing on the development and commercialization of clinical-stage drug candidates for central nervous system disorders.

You can sell covered calls on VANDA PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VNDA (prices last updated Fri 4:16 PM ET):

VANDA PHARMACEUTICALS (VNDA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
17.25 +0.05 17.20 17.40 220K - 0.9B
Covered Calls For VANDA PHARMACEUTICALS (VNDA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 17 0.65 16.75 1.5% 24.9%
Jul 20 17 1.10 16.30 4.3% 27.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. Its product portfolio includes Fanapt and Tasimelteon. The Fanapt product is a compound for the treatment of schizophrenia, the oral formulation of, which is currently being marketed and sold in the U.S. by Novartis. The Tasimelteon product is a compound for the treatment of sleep and mood disorders, including circadian rhythm sleep disorders, which is currently in clinical development. Vanda Pharmaceuticals was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.